Conrad Prebys Foundation provides $3 million for pediatric brain cancer research

The Conrad Prebys Foundation provides $3 million to Robert Wechsler-Reya, Ph.D., and his team of researchers to advance a potential drug to treat medulloblastoma—the most common malignant brain tumor in children.

Alumni adventures: Catching up with student intern Daniel Million

Million reflects on how a summer internship at Sanford Burnham Prebys accelerated his scientific career.

Fighting rare diseases: Finding treatments and bringing hope to families

Two patients whose lives were saved by discoveries made by Hudson Freeze, Ph.D., and José Luis Millán, Ph.D., joined the scientists for a conversation about what this work means to them and how their lives have been impacted.

Scientists design potential drug for triple-negative breast cancer

Drug candidate blocks autophagy, a cellular recycling process that cancer cells hijack as a way to resist treatment.

Mining “junk DNA” reveals a new way to kill cancer cells

Scientists unearth a previously unknown vulnerability for cancer and a promising drug candidate that leverages the approach.